BeyondSpring (BeyondSpring) Debt-to-Asset : 0.16 (As of Dec. 2023)

View and export this data going back to 2017. Start your Free Trial

What is BeyondSpring Debt-to-Asset?

BeyondSpring's Short-Term Debt & Capital Lease Obligation for the quarter that ended in Dec. 2023 was $0.63 Mil. BeyondSpring's Long-Term Debt & Capital Lease Obligation for the quarter that ended in Dec. 2023 was $3.36 Mil. BeyondSpring's Long-Term Debt & Capital Lease ObligationTotal Assets for the quarter that ended in Dec. 2023 was $24.81 Mil. BeyondSpring's debt to asset for the quarter that ended in Dec. 2023 was 0.16.

BeyondSpring Debt-to-Asset Historical Data

The historical data trend for BeyondSpring's Debt-to-Asset can be seen below:

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.

* Premium members only.

BeyondSpring Debt-to-Asset Chart

BeyondSpring Annual Data

Trend

Dec14

Dec15

Dec16

Dec17

Dec18

Dec19

Dec20

Dec21

Dec22

Dec23

Debt-to-Asset

Get a 7-Day Free Trial

0.09

0.04

0.11

0.16

BeyondSpring Quarterly Data
	Mar18	Jun18	Sep18	Dec18	Mar19	Jun19	Sep19	Dec19	Mar20	Jun20	Sep20	Dec20	Mar21	Jun21	Sep21	Dec21	Jun22	Dec22	Jun23	Dec23
Debt-to-Asset	Get a 7-Day Free Trial															0.04	0.08	0.11	0.14	0.16

Competitive Comparison of BeyondSpring's Debt-to-Asset

For the Biotechnology subindustry, BeyondSpring's Debt-to-Asset, along with its competitors' market caps and Debt-to-Asset data, can be viewed below:

* Competitive companies are chosen from companies within the same industry, with headquarter located in same country, with closest market capitalization; x-axis shows the market cap, and y-axis shows the term value; the bigger the dot, the larger the market cap. Note that "N/A" values will not show up in the chart.

BeyondSpring's Debt-to-Asset Distribution in the Biotechnology Industry

For the Biotechnology industry and Healthcare sector, BeyondSpring's Debt-to-Asset distribution charts can be found below:

* The bar in red indicates where BeyondSpring's Debt-to-Asset falls into.

BeyondSpring Debt-to-Asset Calculation

Debt to Asset measures the financial leverage a company has.

BeyondSpring's Debt-to-Asset for the fiscal year that ended in Dec. 2023 is calculated as

Debt-to-Asset	=	Total Debt			/	Total Assets
	=	(Short-Term Debt & Capital Lease Obligation	+	Long-Term Debt & Capital Lease Obligation)	/	Total Assets
	=	(0.631	+	3.364)	/	24.808
	=	0.16

BeyondSpring's Debt-to-Asset for the quarter that ended in Dec. 2023 is calculated as

Debt-to-Asset	=	Total Debt			/	Total Assets
	=	(Short-Term Debt & Capital Lease Obligation	+	Long-Term Debt & Capital Lease Obligation)	/	Total Assets
	=	(0.631	+	3.364)	/	24.808
	=	0.16

BeyondSpring (NAS:BYSI) Debt-to-Asset Explanation

In the calculation of Debt-to-Asset, we use the total of Short-Term Debt & Capital Lease Obligation and Long-Term Debt & Capital Lease Obligation divided by Total Assets.

BeyondSpring Debt-to-Asset Related Terms

Thank you for viewing the detailed overview of BeyondSpring's Debt-to-Asset provided by GuruFocus.com. Please click on the following links to see related term pages.

BeyondSpring (BeyondSpring) Business Description

Industry

GURUFOCUS.COM » STOCK LIST » Healthcare » Biotechnology » BeyondSpring Inc (NAS:BYSI) » Definitions » Debt-to-Asset

Comparable Companies

Traded in Other Exchanges

N/A

Address

28 Liberty Street, 39th Floor, New York, NY, USA, 10005

Website

https://www.beyondspringpharma.com

BeyondSpring Inc is engaged in clinical-stage biopharmaceutical activities focused on the development of cancer therapies. It is also focused on including immuno-oncology agents. It has two reportable segments Plinabulin pipeline and the TPD platform. It has a scalable business model integrating clinical resources in the United States and China.